NEW: No-Cost StreetSmart Live! Events. This type of intellectual capital is usually not made available to the general public. Learn More

The Latest Life Sciences Tools & Diagnostics Articles from Streetwise Reports


Bringing Order to Information Chaos Is a Necessity in the Age of COVID-19

  ()
Leonovus, a data storage and security technology firm, positions its software to enable healthcare groups to organize massive amounts of COVID/public health data. read more >

Fluidigm Shares Climb 34% After FDA Authorizes Saliva-Based COVID-19 Test

  ()
Fluidigm Corp. shares reached a new 52-week high after the firm reported the FDA granted Emergency Use Authorization for saliva-based Advanta Dx SARS-CoV-2 RT-PCR Assay for COVID-19. read more >

Firm's Home Health Monitoring System Provides the 'Most Comprehensive Offering in the Telehealth Space'

  ()
As the Covid pandemic accelerates the adoption of telemedicine technology, Reliq Health Technologies' recent contracts represent exponential growth. read more >
News Update

Canadian Biotech Advances Antibodies, Diagnostics Programs in Q2/20

News Update
  ()
One highlight is ProMIS Neurosciences' development of a SARS CoV-2 antibody test. read more >

$18.5 Billion Merger Could Mean Big Gains for These Five Tiny Telemedicine Stocks

Contributed Opinion
  ()
Independent financial analyst Matt Badiali examines five small companies poised to profit as digital health becomes mainstream during the coronavirus pandemic. read more >

US Immunology Firm Lands Government Contract, Raises Cash

Research Report
  ()
These two CytoSorbents events are discussed in a Dawson James report. read more >
News Update

Tech Firm Explains Key Feature of its Contact Tracing Solution

News Update
  ()
Loop Insights' technology lacks the adoption challenges that app-based solutions face. read more >

Fulgent Genetics' Shares Reach New 52-Week High After Posting 105% Increase in Q2 Revenue

  ()
Shares of Fulgent Genetics traded 22% higher after the company reported it posted a record $17.1 million in Q2/20 revenue and completed a record 180,513 billable tests in the quarter. read more >
News Update

Mobile Health Tech Firm Joins with US Healthcare Group to Bring Care Platform to 50,000 Patients

News Update
  ()
Reliq Health Technologies reported it has entered into a new contract with Diversified Healthcare Partners to provide its iUGO Care platform to more than 50,000 patients in three U.S. states. read more >

Coverage Initiated on 'Emerging Colossus in Diagnostics and Life Science'

Research Report
  ()
Meridian Bioscience's business segments, revenue and growth as well as COVID-19's positive impact on them are reviewed in an H.C. Wainwright & Co. report. read more >

Biopharma's Therapeutic Jumps to Phase 2 Testing for COVID-19 'to Shut Down the Cytokine Storm'

Research Report
  ()
A development update on Sorrento Therapeutics' three coronavirus-related products is provided in a Dawson James report. read more >

Cheap Valuation and Fastest Revenue Growth in Telemedicine? Analyst Says Yes.

Contributed Opinion
  ()
In the time of Covid-19, Peter Epstein of Epstein Research breaks down the investment opportunity offered by CloudMD. read more >

Virtual Healthcare Tech Firm's Contract in Puerto Rico Is Its Largest by 400%

  ()
Reliq Health Technologies' agreement with digiiMED makes its platform available to more than 200,000 patients. read more >
News Update

Biotech Partners to Develop, Offer Alzheimer's Disease Tests

News Update
  ()
ProMIS Neurosciences and its collaborator make their relationship official with a joint venture agreement. read more >

Preclinical COVID-19 Vaccine Data 'Encouraging'

Research Report
  ()
Updates on Sorrento Therapeutics' two coronavirus-related products are provided in an H.C. Wainwright & Co. report. read more >

Invitae Corp. Enters into Definitive Agreement to Acquire ArcherDX

  ()
Shares of Invitae Corp. traded 40% higher after the company reported it will acquire ArcherDX in a combination cash and stock deal valued at around $1.4 billion. read more >
News Update

Biotech Makes 'Significant Progress' Creating Highly Accurate COVID-19 Antibody Test

News Update
  ()
ProMIS Neurosciences states that the current version of the ProMIS-BCNI assay achieves 99.9% sensitivity and 99.5% specificity for SARS CoV-2, the coronavirus causing COVID-19. read more >

Mackie Research: Small Cap a World Leader in Health and Safety Wearables

Contributed Opinion
  ()
Mackie Research believes Blockchain Holdings' TraceSafe tracking platform could tap into the "exceptionally large market" for contact tracing during the Covid-19 pandemic. read more >
News Update

AI Firm Receives Grant to Create Deep Learning Tools to Enhance Organ Donation Processes

News Update
  ()
Xtract AI has secured a CA$150,000 grant from the Innovative Solutions Canada program to utilize artificial intelligence to increase organ donations and improve transplant success rates. read more >
News Update

AI Firm Develops Tool That Helps Radiologists Diagnose COVID-19

News Update
  ()
Patriot One Technologies and its partners create a model that automatically calculates, from a radiological scan, the degree of a patient's affected lungs, a COVID-19 indicator. read more >
News Update

Surgical Equipment Firm Delivers Innovative Imaging Systems to Leading Urologists

News Update
  ()
Imagin Medical delivered two functional i/Blue™ Imaging Systems for use in conducting in vivo studies and virtual demonstrations for evaluation by leading urologists. read more >
News Update

Biotech Partnership to Develop Diagnostic Assay for Alzheimer's Disease

News Update
  ()
With its work on this and a SARS-CoV-2 test, ProMIS Neurosciences is applying its technology platform in new ways. read more >
News Update

Surgical Imaging Company Provides Update on COVID-19 Impact

News Update
  ()
Imagin Medical reported that its actions have mitigated the impact of the coronavirus on its business operations. read more >
News Update

Biotech Expands Antibody Research Across Multiple Neurodegenerative Diseases and Covid-19

News Update
  ()
ProMIS Neurosciences advances its various antibody programs related to neurodegenerative diseases and viral infections such as Covid-19. read more >
News Update

Biotech Advances Accurate SARS CoV-2 Antibodies Detection Test

News Update
  ()
Testing and validation of ProMIS Neurosciences' antibody targets will be conducted over the coming weeks. read more >
Showing Results: 1 to 25 of 29 Next

Get Our Streetwise Reports Newsletter Free and be the first to know!

A valid email address is required to subscribe